Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy.
Devlin
Shane M
SM
Cedars-Sinai Medical Center, Inflammatory Bowel Disease Center, 8730 Alden Drive, Suite E221, Los Angeles, CA 90048, USA. devlins@cshs.org
Hu
Bing
B
Ippoliti
Andrew
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D007813:Laparotomy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D009091:Mucormycosis / Q000150:complications* / Q000175:diagnosis / Q000382:microbiology; D012233:Rhizopus / Q000302:isolation & purification; D012422:Rupture, Spontaneous; D013275:Stomach Rupture / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000069285:Infliximab; D015122:Mercaptopurine